Prescription drug · ANDA
Morphine Sulfate NDC 0115-1280
Morphine sulfate 60 mg/1 · Capsule, Extended release · Oral · Amneal Pharmaceuticals of New York LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0115-1280-01 | 00115128001 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-01)Marketed from Apr 12, 2016 | |
| 0115-1280-03 | 00115128003 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-03)Marketed from Apr 12, 2016 | |
| 0115-1280-08 | 00115128008 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1280-08)Marketed from Apr 12, 2016 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Morphine Sulfate
- Generic name (nonproprietary)
- morphine sulfate
- Active ingredients
- Morphine sulfate — 60 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 200411
- Marketing start
- Listing expires
- DEA schedule
- CII
- Other FDA classes
- Full Opioid Agonists (Mechanism)
- Identifiers
- Product ID 0115-1280_b2330bfc-8b32-421e-ade5-2076ee23cebbSPL ID b2330bfc-8b32-421e-ade5-2076ee23cebbSPL set ID f7e9a4b3-a2ee-4f0a-becd-6ef90867332bRxCUI 892345, 892352, 892554, 892596, 894801, 894814, 1303736UNII X3P646A2J0UPC 0301151281011, 0301151280014
- Pharmacologic class
- Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400115128001followed by a unit qualifier and the quantityPackage 00115-1280-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Morphine sulfate extended-release capsules are indicated for the management of severe and persistent pain, that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Limitations of Use: Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.1) ], reserve opioid analgesics, including morphine sulfate extended-release capsules for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. M…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 200411
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Morphine Sulfate | Morphine sulfate 20 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1277 |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1278 |
| Morphine Sulfate | Morphine sulfate 50 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1279 |
| Morphine Sulfate | Morphine sulfate 80 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1281 |
| Morphine Sulfate | Morphine sulfate 100 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1282 |
| Morphine Sulfate | Morphine sulfate 40 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1479 |